Cargando…
Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia
PURPOSE: Preoperative use of 5α-reductase inhibitors (5ARIs) may cause fibrosis of the prostate tissue and reduce the efficiency of thulium laser surgery for treating benign prostate hyperplasia (BPH). Thus, we investigated the effects of preoperative 5ARI use in this setting. MATERIALS AND METHODS:...
Autores principales: | Chung, Jae Seung, Seo, Won Ik, Oh, Cheol Kyu, Kim, Seong Cheol, Park, Myung Chan, Park, Sang Hyun, Yu, Jihyeong, Lee, Chan Ho, Kim, Wansuk, Park, Tae Yong, Min, Kweon Sik, Chung, Jae Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Urological Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946814/ https://www.ncbi.nlm.nih.gov/pubmed/31942465 http://dx.doi.org/10.4111/icu.2020.61.1.67 |
Ejemplares similares
-
Efficacy and Safety of 120-W Thulium:Yttrium-Aluminum-Garnet Vapoenucleation of Prostates Compared with Holmium Laser Enucleation of Prostates for Benign Prostatic Hyperplasia
por: Hong, Kai, et al.
Publicado: (2015) -
AB060. Long-term outcome following thulium vaporesection of the prostate
por: Zhang, Zhaocun, et al.
Publicado: (2017) -
Efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for vitreous floaters
por: Luo, Jihan, et al.
Publicado: (2018) -
Neodymium-Yttrium Aluminium Garnet Laser Capsulotomy Energy Levels for Posterior Capsule Opacification
por: Bhargava, Rahul, et al.
Publicado: (2015) -
Neodymium-doped yttrium aluminium garnet laser treating cysts of the ciliary body with glare
por: He, Tian-Rui, et al.
Publicado: (2019)